| Literature DB >> 28920233 |
Dian-Sheng Zhong1,2, Lin-Lin Sun2, Li-Xia Dong1.
Abstract
LKB1 is a serine/threonine protein kinase mutated in patients with Peutz-Jeghers syndrome. Biallelic inactivation of LKB1 is present in up to 30% of cases of non-small cell lung cancer (NSCLC). As a tumor suppressor, LKB1 functions in arresting the cell cycle and inhibiting cell growth. LKB1 leads to induction of p21/WAF1 expression in a p53-dependent mechanism, which is mediated by cytoplasmic LKB1 initiating negative regulation of cell growth or nuclear LKB1 directly involved in transcriptional regulation of p21/WAF1. Alternatively, p53 and p21/WAF1-independent mechanism of regulating cell cycle by LKB1 is also reported.Entities:
Keywords: LKB1; cell cycle; lung cancer; p21/WAF1; p53
Year: 2013 PMID: 28920233 DOI: 10.1111/1759-7714.12003
Source DB: PubMed Journal: Thorac Cancer ISSN: 1759-7706 Impact factor: 3.500